申请人:RORER INTERNATIONAL (OVERSEAS) INC.
公开号:EP0090360A2
公开(公告)日:1983-10-05
New quinoline compound, and the corresponding 1,2-; 1,3-; and 1,4-benzodiazines, the quinoline compounds being of the formula:
and salts thereof, wherein
R1 and R2 are independently hydrogen, lower alkyl, halo, trifluoromethyl, amino, lower alkyl amino, lower acylamino, cyano, aryl, aryl/lower alkylene, nitro, lower alkynyl, lower alkenyl, lower alkyl sulfinyl, lower alkyl sulfonyl, lower alkoxycarbonyl, carboxyl, lower alkoxy, lower alkanoyl, or lower alkenoyl, Y is oxygen, sulfur, nitrogen or R3N wherein R3 is hydrogen, lower alkyl, alkenyl, alkynyl, aryl, aralkyl, acyl, aminoalkyl, or carboxyalkyl,
Z is oxygen, sulfur or nitrogen, X is cyano, carbalkoxyl, carboxyl, formyloximino, tetrazolyl, carbalkoxyalkyl or carboxyalkyl, and m is 0 or 1, are useful as medicinals, especially for treatment of asthma, and/or as intermediates in the preparation of compounds useful for treating asthma.
新的喹啉化合物,以及相应的 1,2-;1,3-;和 1,4-苯并二氮杂卓,这些喹啉化合物的式为
及其盐类,其中
R1和R2独立地为氢、低级烷基、卤代、三氟甲基、氨基、低级烷基氨基、低级酰氨基、氰基、芳基、芳基/低级亚烷基、硝基、低级炔基、低级烯基、低级烷基亚磺酰基、低级烷基磺酰基、低级烷氧基羰基、低级羧酰基、低级烷氧基羰基、低级烷氧基羰基、低级烷氧基羰基、Y 是氧、硫、氮或 R3N,其中 R3 是氢、低级烷基、烯基、炔基、芳基、芳烷基、酰基、氨基烷基或羧基、
Z为氧、硫或氮,X为氰基、碳烷氧基、羧基、甲酰亚胺基、四唑基、碳烷氧基烷基或羧基,m为0或1,可用作药物,特别是治疗哮喘的药物,和/或用作制备治疗哮喘的化合物的中间体。